These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8578607

  • 1. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
    Whitfield JF, Morley P.
    Trends Pharmacol Sci; 1995 Nov; 16(11):382-6. PubMed ID: 8578607
    [Abstract] [Full Text] [Related]

  • 2. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis.
    Whitfield JF, Morley P, Willick GE.
    Treat Endocrinol; 2002 Nov; 1(3):175-90. PubMed ID: 15799210
    [Abstract] [Full Text] [Related]

  • 3. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.
    Greenfield EM, Shaw SM, Gornik SA, Banks MA.
    J Clin Invest; 1995 Sep; 96(3):1238-44. PubMed ID: 7657797
    [Abstract] [Full Text] [Related]

  • 4. The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
    Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ, Nilssen MH.
    Bone; 1995 Jun; 16(6):603-10. PubMed ID: 7669436
    [Abstract] [Full Text] [Related]

  • 5. Recombinant parathyroid hormone in the management of osteoporosis.
    Compston J.
    Calcif Tissue Int; 2005 Aug; 77(2):65-71. PubMed ID: 16059774
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.
    Henriksen K, Andersen JR, Riis BJ, Mehta N, Tavakkol R, Alexandersen P, Byrjalsen I, Valter I, Nedergaard BS, Teglbjaerg CS, Stern W, Sturmer A, Mitta S, Nino AJ, Fitzpatrick LA, Christiansen C, Karsdal MA.
    Bone; 2013 Mar; 53(1):160-6. PubMed ID: 23234813
    [Abstract] [Full Text] [Related]

  • 7. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J.
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis.
    Debiais F.
    Joint Bone Spine; 2003 Dec; 70(6):465-70. PubMed ID: 14667554
    [Abstract] [Full Text] [Related]

  • 10. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD, Wronski TJ.
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [Abstract] [Full Text] [Related]

  • 11. PTH: a future role in the management of osteoporosis?
    Reeve J.
    J Bone Miner Res; 1996 Apr; 11(4):440-5. PubMed ID: 8992874
    [No Abstract] [Full Text] [Related]

  • 12. Effects of Intermittent Parathyroid Hormone 1-34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women.
    Tang Y, Xia H, Kang L, Sun Q, Su Z, Hao C, Xue Y.
    Med Sci Monit; 2019 Jan 08; 25():259-268. PubMed ID: 30620727
    [Abstract] [Full Text] [Related]

  • 13. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y, Jee WS, Chen Y, Gasser J, Ke HZ, Li XJ, Kimmel DB.
    J Bone Miner Res; 1995 Nov 08; 10(11):1726-34. PubMed ID: 8592950
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the abilities of human parathyroid hormone(1-31)NH2 and human parathyroid hormone-related protein(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats.
    Whitfield JF, Morley P, Willick GE, Ross V, Langille R, MacLean S, Barbier J, Isaacs RJ, Ohannessian-Barry L.
    Calcif Tissue Int; 1997 Oct 08; 61(4):322-6. PubMed ID: 9312203
    [Abstract] [Full Text] [Related]

  • 16. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].
    Delling G, Dreyer T, Hahn M, Vogel M, Rittinghaus EF, Hesch RD.
    Z Orthop Ihre Grenzgeb; 1990 Oct 08; 128(1):1-5. PubMed ID: 2138378
    [Abstract] [Full Text] [Related]

  • 17. A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis.
    Sone T, Fukunaga M, Ono S, Nishiyama T.
    Miner Electrolyte Metab; 1995 Oct 08; 21(1-3):232-5. PubMed ID: 7565456
    [Abstract] [Full Text] [Related]

  • 18. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
    Liu CC, Kalu DN, Salerno E, Echon R, Hollis BW, Ray M.
    J Bone Miner Res; 1991 Oct 08; 6(10):1071-80. PubMed ID: 1796755
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the ability of recombinant human parathyroid hormone, rhPTH-(1-84), and hPTH-(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats.
    Whitfield JF, Morley P, Willick GE, Ross V, MacLean S, Barbier JR, Isaacs RJ, Ohannessian-Barry L.
    Calcif Tissue Int; 1997 Jan 08; 60(1):26-9. PubMed ID: 9030476
    [Abstract] [Full Text] [Related]

  • 20. Cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats.
    Whitfield JF, Morley P, Willick G, Langille R, Ross V, MacLean S, Barbier JR.
    J Bone Miner Res; 1997 Aug 08; 12(8):1246-52. PubMed ID: 9258755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.